Early research (Phase 1)Temporarily pausedNCT03462004
What this trial is testing
Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein
Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 30